The developmentally regulated loss of female germ cells at various stages of pre-and post-natal development is considered a normal physiological process ensuring the greatest chance for ovulation of viable, fertilizable oocytes. However, abnormally high rates of attrition often result in subclinical or clinical infertility or the premature termination of fertility (for example, reproductive senescence or human menopause). Ovarian follicle atresia in all vertebrates studied to date is mediated via apoptosis, a process that can be initiated from within ovarian germ or follicle somatic cells, or in response to extrafollicular physiological (for example, cytokines) and pathological (for example, viral) signals. Caspases represent a family of intracellular cysteine proteases the actions of which are linked both to the initial and final stages of apoptosis in virtually all types of vertebrate cell. Moreover, recent studies have implicated additional intracellular factors in the mediation of the survival or death of vertebrate ovarian follicles. These factors include the Bcl-2 family of death-inducing and -suppressing proteins, inhibitor of apoptosis proteins (IAPs), membrane-anchored and soluble receptors (for example, tumour necrosis factor receptor family, plus receptor-associated proteins) and cell signalling pathways (for example, adenylyl cyclase-cAMP, mitogenactivated protein kinase and phosphoinositol-3-kinase-Akt). Virtually all of these factors appear to interact with the caspase cascade of proteolytic activity.
Apoptosis mediated by caspases
Apoptosis occurs in eukaryotes (including plants) and prokaryotes (Aravind et al., 1999) . Genetic studies in the nematode Caenorhabditis elegans identified three fundamental components of the apoptotic pathway that are now known to be conserved in all eukaryotes (Miura and Yuan, 1996) . Ced-9 is a negative regulator of apoptosis functionally related to the mammalian Bcl-2 family of death-suppressing proteins. By contrast, Ced-3 is an orthologue from the family of mammalian caspases that acts as an effector of the cell-death pathway, whereas Ced-4 (which is orthologous to the mammalian apoptosis protease-activating factor-1, or Apaf-1) is a regulator of Ced-3-caspase activation. Loss of function mutations of either the ced-3 or ced-4 genes in C. elegans results in an abnormal increase in the number of germ cells, hyperplasia of the gonad and a subsequent decrease in the number of mature oocytes available for fertilization (Gumienny et al., 1999) .
Apoptosis in vertebrate species involves well-organized morphological and biochemical processes characterized by membrane blebbing, cell shrinkage, DNA fragmentation (oligonucleosome formation), and the formation of membrane-enclosed vesicles (apoptotic bodies). A physiological consequence of apoptotic (compared with necrotic) cell death is the elimination of affected cells without the initiation of an inflammatory response. Apoptosis is a highly regulated process involving the sequential In the vertebrate ovary, apoptosis is the process by which excess or non-viable germ and granulosa cells are eliminated early in ontogeny (often beginning before birth), and thereafter continuously throughout reproductive life. Accordingly, an excessively high rate or abnormal triggering of such cell death (and, by implication, follicle atresia) can negatively affect fertility. Programmed cell death involves the integration of many pathways and intracellular proteins, and central among these at almost every stage are members of the caspase family. Relatively little attention has been focused upon the ovary with regards to elucidating initiator and effector members of the caspase family, and pathways by which they are activated and inactivated. The present review briefly describes vertebrate caspases and the regulation of their function in non-ovarian tissues. Subsequently, the status of caspase expression and function in orchestrating apoptotic cell death in ovarian germ and follicle somatic cells is considered. The most compelling results implicating specific caspases in ovarian function have been derived from mouse single and double knockout model systems. The final outcome of continued studies, in addition to providing information regarding understanding and management of infertility, will influence the development of strategies to treat ovarian cancers and ameliorate the adverse effects of their therapy (for example, chemotherapy). activation of multiple caspases, each of which cleaves target substrates at specific aspartic acid residues. A number of non-caspase proteases implicated in apoptosis (for example, granzyme B, cathepsins, calpains and the protease complex) have been reviewed elsewhere (Johnson, 2000) and will not be considered in this review.
Vertebrate caspases
The mammalian caspase family includes 14 members (caspases 1-14) (Hu et al., 1998; Humke et al. 1998; Wolf and Green, 1999) (Fig. 1) . Several of these, including caspases 2, 3, 9, 11 and 12, have been implicated directly in mediating apoptosis within the ovary using genetic models (for examples, see Bergeron et al., 1998; Matikainen et al., 2001; Morita et al., 2001) . Phylogenetic analysis of members of the caspase family has resulted in the classification of caspases into five lineages: (i) caspases 1, 4, 5, 11, 12 and 13 comprise the interleukin-1β-converting enzyme (ICE), or caspase 1 subfamily (mainly involved in the processing of pro-inflammatory cytokines); (ii) caspase 14; (iii) caspases 3, 6, 7, 8 and 10 belong to the caspase 3 subfamily; (iv) caspase 2; and (v) caspase 9 (Wang and Gu, 2001) .
All caspases are translated as inactive zymogens that contain a variable length prodomain and one or more heterodimerization modules, depending upon their function and position within the caspase cascade. For example, upstream initiator caspases such as caspases 8 and 10 contain two death effector domains (DED), whereas caspases 2 and 9 and ICE-related caspases contain a caspase recruitment domain (CARD), in addition to the proteolytic carboxyterminus. Binding of caspases to specific adaptor molecules via DED or CARD domains results in caspase autoactivation together with the activation of effector (or executioner) caspases. The functional carboxy-terminus of all caspases consists of large (for example, p20) and small (for example, p10) subunits that are cleaved at caspasespecific sites (the carboxy side of an aspartate residue) before activation. By comparison, downstream effector caspases contain only a variable length prodomain plus the functional carboxy-terminus domain. Processed subunits LG SM CARD
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LG SM from two procaspase zymogens self-associate (to produce so-called homo-hetero dimers) and form two active enzyme sites at opposite ends of the complex (Earnshaw et al., 1999) . Effector caspases cleave critical cellular proteins, such as nuclear lamins, cytoskeletal proteins, and the inhibitor of caspase-activated DNase, ICAD. For instance, cleavage of the ICAD permits activation of caspaseactivated DNase (CAD), the endonuclease responsible for oligonucleosome formation. Six caspase orthologues have been at least partially characterized to date in Aves (chicken caspases 1, 2, 3, 6, 8 and 9), and each of these is expressed within the ovary (Johnson et al., 1997 (Johnson et al., , 1998a Johnson and Bridgham, 2000 
Caspase activation and cell death signalling
Two general intracellular pathways involving initiator caspases that mediate apoptosis have so far been identified. One upstream pathway promoted by the activation of several members of the tumour necrosis factor receptor (TNF-R) family that contain an intracellular death domain (DD) results in the processing of the initiator caspases, caspases 8 or 10, or both (Fig. 2) . For instance, Fas-induced cell death is mediated by the recruitment and activation of caspase 8 via the Fas adaptor protein, Fas-associated death domain (FADD; Strasser and Newton, 1999) . Whereas a FADD death domain is required for association with the death receptor to form the death-inducing signal complex (DISC), a FADD death effector domain (DED) is critical for the recruitment of caspase 8. Conversely, inhibition of such death receptor-induced activation may be affected by a FADD-like ICE inhibitory protein (FLIP), which competitively blocks the processing of the procaspase at the DISC (Budihardjo et al., 1999) . The overall importance of FLIP expression in attenuating apoptotic cell death is suggested by the finding that FLIP -/-mouse embryos fail to survive past day 10.5 (Yeh et al., 2000) .
An alternative upstream pathway involving an initiator caspase occurs after a perturbation of the mitochondria (for example, one induced by chemotherapeutic drugs, oxidative stress or DNA damage), which promotes the release of mitochondrial cytochrome C and the intermembrane protein DIABLO-Smac to the cytosol (Ekert et al., 2001) . Cytosolic cytochrome C mediates the formation of a high molecular weight complex consisting of Apaf-1 and caspase 9 (the apoptosome complex), and the subsequent processing of caspase 9, whereas a primary action of DIABLO-Smac is to inactivate IAPs. Autoactivation of either caspase 8 or caspase 9 eventually initiates the processing of an effector caspase such as caspase 3, 6 or 7, and the full potentiation of the caspase cascade.
Not unexpectedly, caspase activation and activity is regulated tightly by a variety of cellular pro-and antiapoptotic proteins, including members of the Bcl-2-related family and IAPs. Given the abundance of information derived from both primary and transformed cell lines, only a few pertinent examples will be provided here (for more complete reviews, see Schendel et al., 1998; Miller, 1999) . Anti-apoptotic members of the Bcl-2 family, such as Bcl-2 and Bcl-xLong, consist of four Bcl-2 homology (BH) domains (BH1-4) plus a transmembrane region for anchoring to mitochondria. It has been proposed that such proteins form ion channels within the mitochondrial membrane, and help maintain mitochondrial integrity by allowing the export of H + ions from the inner mitochondrial space. Overexpression of Bcl-2 can inhibit agonist (for example, resveratrol)-induced apoptosis by preventing cytochrome C release and caspase 9 activation (Park et al., 2001) . Similarly, staurosporine-induced caspase 9-like activity and the progression of apoptosis is attenuated by chicken Bcl-xLong (Fig. 3) . Such results clearly place antiapoptotic proteins of the Bcl-2 family upstream of caspase activation.
Pro-apoptotic Bcl-2-related proteins, such as Bid, Bad, Bik and Bim, contain a single BH3 domain and are capable of counteracting the cytoprotective effects of anti-apoptotic Bcl-2 and Bcl-xLong by forming heterodimers. For instance, Fas receptor-activated caspase 8 mediates cleavage of Bid, and the resulting truncated Bid proceeds to neutralize the antiapoptotic activity of Bcl-2 or Bcl-xLong. However, proapoptotic Bax lacks a BH4 domain but maintains the ability to form ion channels within the mitochondrial membrane. After cellular DNA damage, Bax can heterodimerize with and antagonize the anti-apoptotic effects of Bcl-2 or directly promote the release of cytochrome c and DIABLO-Smac (Fig. 2) .
Vertebrate IAPs directly bind to and potently inhibit caspase activation and activity (Deveraux and Reed, 1999) . The second in the series of three baculovirus IAP repeat (BIR) domains derived from X-Linked IAP (XIAP or MIHA) is both necessary and sufficient to suppress caspase 3 and caspase 7 activity, while the third BIR domain of XIAP-MIHA combined with the adjacent zinc-binding RING domain interacts with and inhibits caspase 9 (Deveraux et al., 1999) . Significantly, the inhibitory actions of XIAP-MIHA can be blocked after the release of mitochondrial DIABLO-Smac, which preferentially binds XIAP-MIHA and thus facilitates activation of caspase 9 (Ekert et al., 2001 ).
Receptor-mediated cell signalling pathways, including mitogen-activated protein (MAP) kinase and phosphoinositol-3-kinase-Akt, can attenuate or promote caspase-dependent apoptosis, depending upon the type of cell. Growth factor (for example, epidermal growth factor or insulin-like growth factor I)-induced activation of the phosphoinositol-3-kinase-Akt cell survival pathway inhibits caspase 9 activation and activity directly, presumably via a phosphorylation event (Cardone et al., 1998) , and signalling via Akt prevents serum withdrawal-induced apoptosis in cultured hen granulosa cells (Johnson et al., 2001) . Conversely, downstream effector caspases, such as caspases 3 and 7, target the epidermal growth factor receptor (EGFR) presumably to reduce further cell survival signalling (Bae et al., 2001) .
Collectively, the selective examples above illustrate the complexity and redundancy of the pro-and anti-apoptotic regulatory mechanisms that ultimately determine the status of cellular caspase activity. Given that the myriad of cell signalling pathways and cellular proteins that ultimately balance cell viability and cell death is largely specific to the type of cell, the next section of this review specifically addresses current understanding of these processes within the ovary. Representative pathways leading to initiator caspase activation in the ovary include death domain (DD)-containing receptors from the tumour necrosis factor receptor (TNF-R) family plus a variety of intrinsic and extrinsic factors that can promote the release of mitochondrial cytochrome c (Cyt c) and Diablo-Smac. Receptor activation of the initiator caspase, caspase 8, occurs via an adaptor protein containing both a DD and a death effector domain (DED). Activation of caspase 8 can result in the direct activation of an effector caspase (not shown) or actions at the mitochondria. Bid and Bax represent pro-apoptotic proteins, and Bcl-xL represents one of several potential anti-apoptotic proteins. In granulosa cells, Bcl-xL may, on the basis of its patterns of expression and upregulation via gonadotrophin receptor (GnRH-R) activation, represent one of the more important Bcl-2-related anti-apoptotic proteins. Although granulosa cell survival promoted by growth factor receptor (GF-R) activation is mediated via MAP kinase-Erk and PI-3-kinase-Akt signalling, the downstream mechanisms largely remain to be determined. Apaf-1: apoptosis protease-activating factor-1; CARD: caspase recruitment domain; FLIP: FADD-like interleukin-1β-converting enzyme (ICE) inhibitory protein; IAPs: inhibitor of apoptosis proteins.
Caspases in the vertebrate ovary
Evidence for the involvement of caspases in regulating ovarian germ cell viability During embryonic development, the female ovary is endowed with considerably more germ cells than are present at puberty. This excessive number of germ cells is reduced by two-thirds or more via the process of apoptosis during the late embryonic-early postpartum stage (Morita and Tilly, 1999). Targeted caspase 2 gene inactivation in mouse embryonic stem cells results in a marked decrease in this development-related germ cell death, and consequently, a significantly greater number of primordial follicles within the postnatal ovary compared with the number of follicles in wild-type controls. Moreover, the absence of caspase 2 activity renders germ cells largely resistant to chemotherapeutic drug (doxorubicin)-induced apoptosis (Bergeron et al., 1998) .
Studies with caspase 11-deficient mice showed that females are born with a severe depletion of germ cells (Morita et al., 2001) . In light of considerable previous data implicating caspase 11 as a functional mediator of cytokine processing ( Fig. 1 ; Earnshaw et al., 1999) , it was reasoned that the absence of caspase 11 activity results in a deficiency of fully processed cell survival cytokines within developing oocytes. In fact, a significantly greater proportion of fetal ovarian germ cells derived from caspase 11-deficient mice and cultured in the presence of interleukin 1α (IL-α) or IL-1β survived than did those cultured in the absence of these cytokines. Further experiments with caspase 11-caspase 2 double mutants determined that the germ cell loss observed in caspase 11-deficient females was dependent upon functional caspase 2 activity. These results lead to the conclusion that cytokines processed as a result of caspase 11 activity (including, but not necessarily limited to, IL-1α and IL-1β) suppress downstream effector caspases such as caspase 2.
Prenatal germ cells in cultured ovaries from caspase 9 -/-mice are more resistant to apoptosis induced by cytokine deprivation than are those from wild-type controls (Maravei et al., 2001) , whereas cumulus-denuded oocytes from mature caspase 12 -/-mice are comparatively more resistant to the chemotherapeutic drug doxorubicin (Perez et al., 2001) . Although both these reports provide intriguing evidence for the involvement of caspases 9 and 12 in the regulation of the number of germ cells, the physiological significance in vivo and the precise mechanisms of activation in the ovary remain to be elucidated.
In contrast, caspase 3 activity is apparently not essential for either development-related or chemotherapeutic (for example, doxorubicin)-induced germ cell apoptosis at day 4 after birth, as determined from studies using caspase 3 gene knockout mice (Matikainen et al., 2001) . In light of evidence that additional effector phase members of the caspase family are expressed within the oocyte (for example, caspases 6 and 7; Exley et al., 1999) , it is likely that redundant effector caspases function to ensure the completion of apoptosis. In addition to functional studies of caspases 2, 3, 9 and 11 in pre-and early postnatal oocytes, RT-PCR studies have detected expression of caspases 1, 6 and 7 within oocytes from superovulated mice (Exley et al., 1999) ; however, the activity and function of each caspase within mature oocytes has yet to be established.
Future genetic model systems designed to evaluate the role of additional caspases will likely require the use of conditional knockout model systems (Pru and Tilly, 2001) , as some caspase knockout models (for example, those for caspases 7 and 8) have proven to be lethal to embryos (Zheng et al., 1999) . Nevertheless, results from the various caspase-deficient model systems generated to date have initiated the elucidation of the germ cell-specific pathways (compared with the ovarian somatic cell-specific pathways; Fig. 4 ) responsible for mediating apoptosis both before and after birth. 
Mediation of follicle atresia by caspases
During the postnatal development of primordial through to preantral mammalian follicles, atresia is initiated mainly by the death of the oocyte (Morita and Tilly, 1999) . Germ cell apoptosis may result from either the absence or insufficient availability of cell survival factors (for example, ILs, stem cell factor, leukaemia inhibitory factor and insulinlike growth factor I; Morita and Tilly, 1999), environmental toxins or chemotherapeutics (Robles et al., 2000) . The loss of germ cell viability results in the death of the adjacent somatic cell layer via apoptosis (Fig. 4) . In contrast, atresia in preantral through to preovulatory follicles is frequently characterized by the rapid progression of apoptosis throughout the granulosa layer, which leads ultimately to the demise of the oocyte (Morita and Tilly, 1999; Tilly, 2001) .
Granulosa cells from healthy follicles possess almost exclusively the inactive (unprocessed) form of caspase 3, whereas granulosa cells from atretic follicles demonstrate increased concentrations of activated caspase 3. The active processing of caspase 3 is associated with the cleavage of poly-(ADP-ribose)-polymerase (PARP) and actin, and the formation of oligonucleosomes (Boone and Tsang, 1998) . Unlike the progression in germ cells, the normal progression of apoptosis in granulosa cells from preantral to preovulatory follicles is dependent upon the activity of caspases 3 and 7, as determined from studies using caspase 3 knockout mice (Matikainen et al., 2001 ). This finding reinforces the specificity of cell lineage-dependent apoptotic pathways, and provides for specificity in the paracrine-autocrine signals that initiate germ cell versus somatic cell death.
Moreover, ovaries from caspase 9-deficient mice contain numerous developing follicles that fail to complete atresia owing to an apparent failure of granulosa cell apoptosis (Maravei et al., 2001) . Indirect evidence indicates a role for caspase 9 as an initiator of caspase 3 activity, as Apaf-1 expression in antral follicles is suppressed by gonadotrophin (equine chorionic gonadotrophin) priming (Robles et al., 1999) . Angelastro et al. (2001) have reported ovarian expression of a caspase 9 variant containing a unique carboxy-terminus (caspase 9-carboxy-terminaldivergent) that may act as a dominant-negative isoform, but it remains to be established to what extent this alternatively spliced variant functions to modify the progression of apoptosis within the ovary under physiological conditions.
Although pathways mediating death receptor-induced caspase activation have received less attention, there is evidence for both expression and activity of caspase 8 (but not caspase 10) in granulosa cells (Hu et al., 2001; S. Barton, J. T. Bridgham and A. L. Johnson, unpublished) . Cell survival factors and caspase-mediated cell death in the ovary differ with respect to type of cell. Apoptosis initiated within oogonia and oocytes from primordial to preantral follicles is caspase 2-dependent and can be attenuated by cell survival factors such as interleukin-1α (IL-1α) and IL-1β, retinoic acid, leukaemia inhibiting factor (LIF) via its receptor gp130, insulin-like growth factor I (IGF-I) and IGF-II, and stem cell factor (SCF) via its receptor KIT. The death of the oocyte leads ultimately to granulosa cell death and follicle atresia. In contrast, caspase 3-dependent apoptosis within the granulosa cell layer is a frequent cause of follicle atresia during the antral to tertiary (preovulatory) stages of development. Dark circles represent apoptotic germ or somatic cells. Autocrine and paracrine factors known to promote granulosa survival include LH, FSH, IGF-I, epidermal growth factor (EGF) and transforming growth factor α (TGF-α).
mRNA transcript encoding caspase 3 are extremely low, and IL-1β fails to attenuate the progression of apoptosis in hen granulosa cells (Johnson et al., 1998a) . In addition, various IAPs are expressed within ovarian granulosa cells (cIAP1: Johnson et al., 1998b; Li et al., 1998; XIAP: Asselin et al., 2001; survivin, Fig. 5 ). Nevertheless, much work remains to be done to establish the site of inhibitory action for each IAP within the caspase cascade.
Several intracellular signalling pathways have been linked directly to promoting granulosa cell survival, including pathways involving gonadotrophin-and vasoactive intestinal peptide-induced cAMP formation (Flaws et al., 1995; Johnson et al., 1999) , mitogen-activated protein (MAP) kinase-Erk (Gebauer et al., 1999) and phosphoinositol-3-kinase-Akt (Westfall et al., 2000; Asselin et al., 2001; Johnson et al., 2001 ). For instance, signalling via cAMP probably enhances resistance of hen granulosa cells to apoptosis, at least in part, by increasing expression of the anti-apoptotic proteins Bcl-xLong and cIAP1.
Caspase-mediated regression of the corpus luteum-postovulatory follicle
After an infertile ovulatory cycle in a female mammal, regression of the corpus luteum is a prerequisite to the initiation of a new wave of follicle development. There has been relatively little work directed towards elucidating caspase-dependent pathways involved in corpus luteum regression. As might be predicted, a number of initiator and effector caspases expressed within preovulatory follicles have also been identified within the corpus luteum, including caspases 1, 3 and 9 (Krajewska et al., 1997; Rueda et al., 1999; Khan et al., 2000) . In non-primate species, PGF 2α derived from the uterus is considered a primary initiator of luteal regression. PGF 2α -induced apoptosis within the ovine corpus luteum is associated with both increased mRNA expression and activity of caspase 3 (Rueda et al., 1999) . The actions of PGF 2α may occur, at least in part, as a result of protein kinase C-mediated production of reactive oxygen species (ROS) (Nakamura and Sakamoto, 2001). Moreover, in cows, increased concentrations of the caspase 1 transcript in the corpus luteum occur coincident with the onset of luteolysis (Rueda et al., 1997) . Although caspase 1 activity is associated primarily with the processing of proinflammatory cytokines, it is not yet clear whether this association is involved in the initiation or potentiation of luteal regression.
From an evolutionary perspective, ovulated follicles from avian species rapidly terminate the biosynthesis of progesterone and fail to form a functional corpus luteum. Instead, the residual postovulatory follicle begins to regress via caspase-mediated apoptosis shortly after ovulation (Fig.  6) , and is almost entirely resorbed within 4-6 days after ovulation. No studies have thus far been reported that define the signals and initiator pathways responsible for regression of the postovulatory follicle. 
Conclusions
Although there has been considerable recent progress in defining the caspases involved in regulating the number of germ cells and follicle atresia, and the differences in the involvement of specific caspases in ovarian cell lineage in vertebrate species, there is clearly more to be learned. Further progress in this area will be complicated by the presence of multiple, and potentially redundant, caspase cascades that mediate apoptosis, together with the multiple checks and balances provided by various pro-and antiapoptotic signalling pathways and cellular regulatory proteins expressed within the ovary. Nevertheless, such progress will no doubt impact positively upon the diagnosis and treatment of clinical infertility, the development of strategies to prevent chemotherapy-induced infertility, and the understanding of normal and pathological processes leading to reproductive senescence.
Note added in proof : a recent publication* has documented in caspase 3 null mice the functional requirement for caspase 3 activity in the morphological regression of the corpus luteum after a non-fertile ovulation. 
